Informationen:
Fehler:
ID
23551
Beschreibung
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00576901
Link
https://clinicaltrials.gov/show/NCT00576901
Stichworte
Versionen (1)
- 08.07.17 08.07.17 -
Hochgeladen am
8. Juli 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00576901
Eligibility Breast Cancer NCT00576901
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00576901
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender | Age
Item
female patients, >=18 years of age;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Locally advanced breast cancer inflammatory HER2 negative TNM Breast tumor staging
Item
her2-negative, locally advanced (stage ii or iii) or inflammatory cancer of the breast;
boolean
C3495949 (UMLS CUI [1,1])
C0333348 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0474926 (UMLS CUI [1,4])
C0333348 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0474926 (UMLS CUI [1,4])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Neoplasm Metastasis TNM clinical staging
Item
metastatic disease (stage iv);
boolean
C0027627 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
Prior Therapy Breast Carcinoma
Item
previous treatment for breast cancer;
boolean
C1514463 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
CNS metastases
Item
evidence of cns metastasis;
boolean
C0686377 (UMLS CUI [1])
Aspirin U/day | Avastin | Anti-Inflammatory Agents, Non-Steroidal | Anticoagulants Dose Full
Item
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) nsaids or full dose anticoagulants for therapeutic purposes;
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003211 (UMLS CUI [3])
C0003280 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0443225 (UMLS CUI [4,3])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003211 (UMLS CUI [3])
C0003280 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0443225 (UMLS CUI [4,3])
Cardiovascular Disease
Item
clinically significant cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])